ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study
Clinical Trial Grant
Awarded By
Chimerix, Inc.
Start Date
September 28, 2023
End Date
October 31, 2028
Awarded By
Chimerix, Inc.
Start Date
September 28, 2023
End Date
October 31, 2028